NLRP3 and chronic kidney disease: This study demonstrates that the combination of ultrasound and microbubble therapy can potentiate the inhibitory effect of 5 mg/kg MCC950 on the NLRP3 inflammasome, thereby improving renal function and mitigating renal fibrosis in CKD rats.